Product Description
The offered Gefitinib Tablets are used to treat lung cancer. It works by slowing or stopping the growth of cancer cells. Gefitinib blocks a certain protein (an enzyme called tyrosine kinase). Gefitinib is in a class of medications called kinase inhibitors. It works by blocking the action of a certain naturally occurring substance that may be needed to help cancer cells multiply. The offered Gefitinib tablets are advised to be taken as per the guidance of the doctor.
Targeted Therapy for NSCLCGefitinib tablets are specifically formulated to address non-small cell lung cancer by inhibiting the activity of epidermal growth factor receptors. This targeted action helps to slow the growth and spread of cancer cells, offering a valuable treatment option for eligible adult patients.
Convenient Oral AdministrationThe film-coated, white or off-white tablets are designed for easy oral intake, improving adherence for patients undergoing long-term cancer therapy. Their standard size and round shape make them easy to swallow, providing additional comfort during the treatment process.
Safe and Effective with Proper UseGefitinib is approved by regulatory authorities for NSCLC use and offers stability and efficacy when used as directed. Prescribers monitor patient suitability, especially avoiding use in cases of pregnancy, severe liver impairment, or known hypersensitivity to Gefitinib.
FAQs of Gefitinib Tablets:
Q: How should Gefitinib Tablets 250 mg be taken?
A: Gefitinib Tablets should be taken orally at the same time each day, preferably with water. They can be taken with or without food, but consistency in timing is important. Always follow your doctors instructions regarding dose and duration.
Q: What is the primary benefit of using Gefitinib Tablets in NSCLC treatment?
A: Gefitinib specifically targets the tyrosine kinase activity that drives certain non-small cell lung cancers, slowing tumor growth and progression, and potentially improving survival rates for eligible patients.
Q: When is Gefitinib prescribed for non-small cell lung cancer patients?
A: Gefitinib is prescribed as a first-line monotherapy or after disease progression following treatment with other therapies, especially in adult patients with locally advanced or metastatic NSCLC.
Q: Where should Gefitinib Tablets be stored for optimal stability?
A: Store Gefitinib Tablets below 30C in a dry place away from light. Keeping the medication in its original Alu-Alu blister or strip packaging helps protect it from moisture and contamination.
Q: What are the contraindications associated with Gefitinib Tablets?
A: Gefitinib is contraindicated in individuals who are pregnant, have severe hepatic impairment, or exhibit hypersensitivity to Gefitinib or any of its excipients. Always inform your doctor of your medical history before starting treatment.
Q: What process should be followed if a dose is missed?
A: If you miss a dose of Gefitinib, skip the missed tablet and take the next dose at your regular time. Do not double the dose to make up for the missed one. Consult your healthcare provider for guidance in case of frequently missed doses.